Clearly small-cap drug development companies like Celsion are "news driven" when it comes to movement of the price per share. I am not aware of any specific fundamental catalysts in the near term (although there are many possibilities in terms of updates to their ongoing trials / partnerships / or other) The chart is showing some positive signs of an upturn in the making. This chart displays (1) the recent solid moves through moving averages (the 20 & the 50 day) (2) the break through of a relatively long term resistance trend-line and (3) the short interest covering pattern that has occurred over the last ~12 months.
I have plotted the short interest (as reported by the NASDAQ) at a few points through the last year or so. The fact that total shares held short has decreased by about 80% over the last year suggest to me that the "market" is expecting ~something~ to occur in the near future.
Near-term (3 months) price target is at Nov 2014 highs and the 200 day simple moving average
Hope you enjoy...